Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of OPC-12759 in dry eye
NCT00818324Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jan 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rebamipide ophthalmic solution in dry eye disease (DED), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Jan 2009; status: completed.
02
Drugs
rebamipide ophthalmic solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00818324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818324.